Common Substances That May Contribute to Resistant Hypertension, and Recommendations for Limiting Their Clinical Effects
- PMID: 27671491
- DOI: 10.1007/s11906-016-0682-1
Common Substances That May Contribute to Resistant Hypertension, and Recommendations for Limiting Their Clinical Effects
Abstract
Purpose of review: The purpose of this review is to highlight common or important substances or habits that elevate blood pressure and offer suggestions, based on recent literature, to limit their use or effects.
Recent findings: Despite decades of advice to the general populace from public health authorities to avoid or reduce dietary sodium and non-steroidal anti-inflammatory drug (NSAID) use, more evidence has accumulated from nationwide surveys, clinical trials, and pathophysiological or mechanistic studies that show how important these modalities can (and should) be for hypertensive and prehypertensive individuals and the general population. Other common stimuli that increase blood pressure can be divided into many that are easily avoided (e.g., phenethylamines, anabolic steroids), those that must be continued for important medical reasons (e.g., erythropoietin, tyrosine kinase inhibitors) and therefore require intensified antihypertensive therapy, and a few (e.g., glucocorticoids, hormonal contraceptives) that fall between these two paradigms.
Keywords: Blood pressure; Drug-induced hypertension; Resistant hypertension; Secondary hypertension.
Similar articles
-
Drug-related hypertension and resistance to antihypertensive treatment: a call for action.J Hypertens. 2011 Dec;29(12):2295-309. doi: 10.1097/HJH.0b013e32834c465d. J Hypertens. 2011. PMID: 22002334 Review.
-
Clinical management of drug-induced hypertension: 2013 Practical Recommendations of the Italian Society of Hypertension (SIIA).High Blood Press Cardiovasc Prev. 2014 Mar;21(1):77-9. doi: 10.1007/s40292-014-0038-3. Epub 2014 Feb 18. High Blood Press Cardiovasc Prev. 2014. PMID: 24535939 Review.
-
Lifestyle modifications to prevent and control hypertension. 5. Recommendations on dietary salt. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.CMAJ. 1999 May 4;160(9 Suppl):S29-34. CMAJ. 1999. PMID: 10333851 Free PMC article.
-
Resistant hypertension: an overview of evaluation and treatment.J Am Coll Cardiol. 2008 Nov 25;52(22):1749-57. doi: 10.1016/j.jacc.2008.08.036. J Am Coll Cardiol. 2008. PMID: 19022154 Review.
-
The impact of combinations of non-steroidal anti-inflammatory drugs and anti-hypertensive agents on blood pressure.Adv Clin Exp Med. 2014 Nov-Dec;23(6):993-1000. doi: 10.17219/acem/37357. Adv Clin Exp Med. 2014. PMID: 25618128 Review.
Cited by
-
Use of Prescription Medications That Potentially Interfere With Blood Pressure Control in New-Onset Hypertension and Treatment-Resistant Hypertension.Am J Hypertens. 2018 Nov 13;31(12):1324-1331. doi: 10.1093/ajh/hpy118. Am J Hypertens. 2018. PMID: 30052747 Free PMC article.
-
Key Updates to the 2024 ESC Hypertension Guidelines and Future Perspectives.Medicina (Kaunas). 2025 Jan 23;61(2):193. doi: 10.3390/medicina61020193. Medicina (Kaunas). 2025. PMID: 40005310 Free PMC article. Review.
-
Obesity as an effect modifier of the association between menstrual abnormalities and hypertension in young adult women: Results from Project ELEFANT.PLoS One. 2018 Nov 28;13(11):e0207929. doi: 10.1371/journal.pone.0207929. eCollection 2018. PLoS One. 2018. PMID: 30485368 Free PMC article.
-
Antenatal exposure to nonsteroidal anti-inflammatory drugs and risk of neonatal hypertension.J Clin Hypertens (Greenwich). 2018 Sep;20(9):1334-1341. doi: 10.1111/jch.13354. Epub 2018 Jul 27. J Clin Hypertens (Greenwich). 2018. PMID: 30051971 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials